Drug intelligence / Profile preview

Ichthopaste

Development stage: Unknown
Lead developer: Evolan Pharma
Modality: Small Molecules
Administration: Topical

Overview

Ichthopaste is a medicated dressing consisting of an open-woven cloth bandage impregnated with a topical paste containing 6.32% zinc oxide and 2% ichthammol. Developed and marketed by Evolan Pharma, it is primarily used to treat inflammatory skin conditions and aid in the healing of leg ulcers. The zinc oxide component provides a protective and astringent barrier on the skin, while ichthammol serves as an antiseptic and anti-inflammatory agent. The product is specifically designed to manage conditions such as chronic eczema, dermatitis, varicose eczema, and hyperkeratosis by providing a moist wound-healing environment and protecting the skin from the "itch-scratch cycle."

Brand names: Ichthopaste
Other names: Ichthammol and Zinc Oxide Medicated BandageZinc Oxide and Ichthammol Bandage BP

Beyond the preview

Go deeper on Ichthopaste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ichthopaste.

Explore the full profile